Doruk Altiok, Elif Zeynep Savci, Büşra Özkara, Kamil Alkan, Dilara Sultan Namdar, Gizem Tunçer, Buğrahan Regaip Kilinç, Evren Suiçmez, Güneysu Çetin, Sinan Ünal, Beyza Dönmüş, Zeynep Yağmur Karagülleoğlu, Dilruba Beyza Uncuoğlu, Cansu Tekeli, Hanife Ayşegül Mendi, Vahdi Umut Bengi, Güldane Cengiz Seval, Pelin Kiliç, Evrim Güneş Altuntaş, Devrim Demir-Dora
{"title":"Host variations in SARS-CoV-2 infection.","authors":"Doruk Altiok, Elif Zeynep Savci, Büşra Özkara, Kamil Alkan, Dilara Sultan Namdar, Gizem Tunçer, Buğrahan Regaip Kilinç, Evren Suiçmez, Güneysu Çetin, Sinan Ünal, Beyza Dönmüş, Zeynep Yağmur Karagülleoğlu, Dilruba Beyza Uncuoğlu, Cansu Tekeli, Hanife Ayşegül Mendi, Vahdi Umut Bengi, Güldane Cengiz Seval, Pelin Kiliç, Evrim Güneş Altuntaş, Devrim Demir-Dora","doi":"10.3906/biy-2104-67","DOIUrl":null,"url":null,"abstract":"<p><p>The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the zoonotic pathogen that causes the \"Coronavirus Disease of 2019 (COVID-19)\", and COVID-19 itself is yet to be thoroughly understood. Both the disease as well as the mechanisms by which the host interacts with the SARS-CoV-2 have not been fully enlightened. The epidemiological factors -e.g. age, sex, race-, the polymorphisms of the host proteins, the blood types and individual differences have all been in discussions about affecting the progression and the course of COVID-19 both individually and collectively, as their effects are mostly interwoven. We focused mainly on the effect of polymorphic variants of the host proteins that have been shown to take part in and/or affect the pathogenesis of COVID-19. Additionally, how the procedures of diagnosing and treating COVID-19 are affected by these variants and what possible changes can be implemented are the other questions, which are sought to be answered.</p>","PeriodicalId":23375,"journal":{"name":"Turkish journal of biology = Turk biyoloji dergisi","volume":"45 4","pages":"404-424"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573834/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish journal of biology = Turk biyoloji dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3906/biy-2104-67","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the zoonotic pathogen that causes the "Coronavirus Disease of 2019 (COVID-19)", and COVID-19 itself is yet to be thoroughly understood. Both the disease as well as the mechanisms by which the host interacts with the SARS-CoV-2 have not been fully enlightened. The epidemiological factors -e.g. age, sex, race-, the polymorphisms of the host proteins, the blood types and individual differences have all been in discussions about affecting the progression and the course of COVID-19 both individually and collectively, as their effects are mostly interwoven. We focused mainly on the effect of polymorphic variants of the host proteins that have been shown to take part in and/or affect the pathogenesis of COVID-19. Additionally, how the procedures of diagnosing and treating COVID-19 are affected by these variants and what possible changes can be implemented are the other questions, which are sought to be answered.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
